Health News: 4 November 2026

Massachusetts voters decisively rejected Question 8, a ballot initiative that would have dismantled the state's recreational cannabis industry, with around 76 percent voting against repeal. The decisive victory was celebrated by weed consumers and industry workers, who viewed the outcome as a significant win for the sector.

The result occurred as the rest of the country experienced a political shift, but for local stakeholders, it was a defining moment for the future of recreational weed sales in the state.

A British healthcare worker who tested positive for Ebola in the Democratic Republic of the Congo is being evacuated to the UK for treatment in a specialist high-consequence infectious disease unit. The patient is in stable condition and is expected to arrive in the UK on Wednesday or Thursday. This is the first case involving a British national contracting the virus in the current outbreak, which has spread to Kenya, Uganda, and Nigeria.

Cocaine has become the leading cause of drug poisoning deaths in England and Wales, overtaking heroin for the first time as deaths linked to the substance nearly quadrupled over a decade. Office for National Statistics data shows 1,233 cocaine-related deaths were registered in 2025, slightly more than the 1,210 linked to heroin or morphine.

The overall drug death rate fell for the first time since 2012, though experts noted growing regional inequalities, with the North East experiencing rates more than twice as high as London.

A World Health Organization report says six climate and health interventions could prevent 1.6 million deaths a year, about one in 40, and bring trillions of dollars in benefits. The actions include heat-health warning systems, climate-resilient drinking water, basic sanitation and hygiene, cleaner household fuels, and fossil fuel pricing. Without action, climate-related risks could cause 250,000 premature deaths a year from 2030 to 2050.

The World Health Organization has recommended clinical trials for two new vaccine candidates developed by the University of Oxford, the Serum Institute of India, and Moderna to combat the Bundibugyo Ebola variant. The current outbreak, which began in the Democratic Republic of the Congo in May, has infected more than 10,000 people and killed over 5,300, making it the fastest-growing Ebola epidemic on record.

WHO chief Tedros Adhanom Ghebreyesus urged countries to lift travel restrictions, arguing they punish transparency and harm the response.

Michael Charlton, a physician who led clinical development at Madrigal Pharmaceuticals, filed a federal lawsuit alleging he was forced to resign after raising safety concerns about the company's approved MASH drug. The suit, filed Oct. 9 in the Northern District of Illinois, accuses Madrigal of retaliation under federal whistleblower-protection statutes and seeks reinstatement or damages. The drug is for the liver disease known as MASH.

A Mass General Brigham study found that pulse oximetry-based sleep apnea scoring may undercount breathing events in Black patients, affecting severity classification. In two cohorts, airflow-defined events meeting a 4 percent oxygen-desaturation criterion were about 20 percent less common in Black than white participants. Heart-rate-based scoring showed no comparable racial difference.

A Yale-led trial found that a new prostate cancer drug showed promise in reducing tumor activity and pain in metastatic prostate cancer. In the phase III DASL-HiCaP trial, adding darolutamide to androgen deprivation therapy and radiation improved metastasis-free survival in very high-risk prostate cancer. At four years, the rate was 95 percent with darolutamide versus 88 percent with placebo, a 58 percent risk reduction.

A phase III trial of more than 500 Indian adults with inadequately controlled type 2 diabetes found that a fixed-dose tablet combining dapagliflozin, glimepiride, and metformin improved blood sugar control over 16 weeks compared with glimepiride and metformin tablets. The study, published in Advances in Therapy, reported no serious adverse events. The findings add evidence for triple therapy in a country with a large diabetes burden.

A world-first national program in Australia found that more than a third of infants suspected of having a peanut allergy could safely have the diagnosis removed after undergoing supervised oral food challenges. The study, led by the Murdoch Children's Research Institute, assessed 1,275 infants and found that 35 percent did not react to peanut, allowing them to avoid long-term dietary restrictions.

The findings are changing how the Australian health care system approaches infant food allergies by emphasizing the importance of confirming diagnoses before committing children to treatment.

European cancer organizations warn that the EU's next long-term budget for 2028 to 2034 may lack a dedicated health funding pot, placing ongoing cancer projects at risk. Under the European Commission's proposal, health funding would share a common pot with biotechnology, agriculture, and the bioeconomy under a broader European Competitiveness Fund.

Isabel Rubio of the European Cancer Organisation stated that projects making a real difference, such as training doctors and developing new treatments, now face an uncertain future as negotiations continue.

A UC San Francisco study found that an herbal kudzu supplement helped people with alcohol use disorder reduce binge-drinking days when taken before expected heavy drinking. In a 12-week trial of 120 adults, average binge-drinking days fell from 2.15 to 1.42 per week in the kudzu group, while placebo changed little. Benefits persisted three months after treatment. Binge drinking accounts for over half of about 80,000 annual U.S. alcohol deaths.

Researchers at The George Institute for Global Health found that replacing regular salt with potassium-enriched salt across 193 countries could prevent almost 3 million deaths and 10 million new cardiovascular and kidney disease cases each year. The substitute replaces some sodium chloride with potassium chloride and is endorsed by the World Health Organization. Even partial switching, such as in households, could avert 1.85 million deaths.

A new study published in JAMA Network Open estimates that approximately 75% of deceased NFL players had chronic traumatic encephalopathy (CTE) when they died. The research combines data from the UNITE brain bank with population-level mortality records to correct for the selection bias found in previous autopsy-based studies.

This provides a more accurate assessment of the disease's prevalence among professional players than earlier estimates, which ranged widely due to limited brain donations.

Boston Medical Center researchers found that Massachusetts census tracts with the lowest 1930s redlining grades had 86% higher annual opioid-related overdose death rates than top-graded tracts. The study analyzed 1,829 adult deaths from 2015 to 2019 in 326 tracts. Adjusted rates were 53% higher in still desirable tracts and 61% higher in declining tracts.

Research published in JSCAI found that the annual number of transcatheter aortic valve replacement (TAVR) procedures among patients younger than 70 increased nearly ninefold within one health system, rising from 15 in 2014 to 134 in 2024. The study, which analyzed 5,755 procedures over 11 years, noted that the increase was driven primarily by patients aged 60 to 69.

While TAVR is a minimally invasive alternative to open-heart surgery, researchers emphasize that valve durability and the potential need for future interventions are central considerations for younger patients.

A survey of more than 7,200 adults in the United States, United Kingdom, and Australia found that 7% had experienced at least one form of AI-generated image-based abuse since turning 18. The study, published in the International Journal of Human-Computer Interaction, revealed that men reported experiencing the abuse at more than twice the rate of women, though women reported more negative impacts on their health and safety.

Researchers noted that the true scale of the abuse may be greater because some victims may never know that AI-generated images of them have been created or shared.

A clinical trial spanning Canada and the UK found that a low-energy diet combined with supervised exercise helped 54% of younger adults with early-onset type 2 diabetes achieve remission. The study, published in The Lancet Regional Health Americas, enrolled adults aged 18 to 45 who had been diagnosed with the condition within the previous six years and lived with obesity.

Researchers noted that early-onset type 2 diabetes follows a more aggressive course than diabetes diagnosed later in life, making remission a critical goal for these patients.

A government-funded trial will offer new blood tests to over 20,000 NHS patients aged 45 and over in 200 GP surgeries across England. The tests aim to detect hard-to-diagnose abdominal cancers, such as liver, ovarian, and pancreatic cancer, by looking for proteins or DNA fragments in the blood.

Led by the University of Birmingham, the trial seeks to determine if the tests are accurate enough for wider use, as these cancers are often found only after they have spread.

A national study analyzing over 5 million substance-related emergency care encounters found that cannabis was involved in the majority of visits by adolescents and young adults, while alcohol predominated among older adults. The research, published in The American Journal of Psychiatry, highlights diverging age patterns in substance-related harm across the United States.

Investigators say the findings could help doctors provide more nuanced information to patients about the risks of cannabis and alcohol use at different life stages.